| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070468 | European Journal of Surgical Oncology (EJSO) | 2005 | 7 Pages |
Abstract
Although this study is small, the results are encouraging and suggest the nomogram is a useful tool to estimate the likelihood of positive axillary non-SLN. However, variations in pathological assessment between centres are the major impediment to widespread application of BCN. If SLN positive patients decline the standard recommendation of CAD or entry into clinical trials evaluating the significance of CAD then the BCN could help in decision making.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
N.K. Soni, H.L. Carmalt, D.J. Gillett, A.J. Spillane,